image
Cartesian Therapeutics, Inc. RNAC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.76
-2.4 %
$ 253 M
Market Cap
1.83
P/E
Price Target Average
342.62%
Revenue Forecast Estimate
30.37%
EBIT Estimate
--8.83%
Net Income Estimate
6.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cartesian Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for RNAC of $43.2 , with forecasts ranging from a low of $40 to a high of $45 .
RNAC Lowest Price Target Wall Street Target
40 USD 309.84%
RNAC Average Price Target Wall Street Target
43.2 USD 342.62%
RNAC Highest Price Target Wall Street Target
45 USD 361.07%
Price
Max Price Target
Min Price Target
Average Price Target
4545404035353030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RNAC

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RNAC

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)20162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RNAC

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)20162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029